{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:52:24Z","timestamp":1793047944745,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":74,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 NS015655"],"award-info":[{"award-number":["P01 NS015655"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 NS091856"],"award-info":[{"award-number":["P50 NS091856"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 NS070856"],"award-info":[{"award-number":["RO1 NS070856"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Parkinson's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 RX001631"],"award-info":[{"award-number":["I01 RX001631"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012479","name":"Weston Brain Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Aging Brain"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.nbas.2022.100039","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T16:31:23Z","timestamp":1648485083000},"page":"100039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET study"],"prefix":"10.1016","volume":"2","author":[{"given":"Prabesh","family":"Kanel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sygrid","family":"van der Zee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Sanchez-Catasus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Koeppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.H.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teus","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Albin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas I.","family":"Bohnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbas.2022.100039_b0005","doi-asserted-by":"crossref","unstructured":"Gasiorowska A, Wydrych M, Drapich P, et al. The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain. Front Aging Neurosci 2021; 13: 654932021\/07\/310.3389\/fnagi.2021.654931.","DOI":"10.3389\/fnagi.2021.654931"},{"key":"10.1016\/j.nbas.2022.100039_b0010","series-title":"Handbook of Clinical Neurology","first-page":"159","article-title":"Chapter 10 - Spatial topography of the basal forebrain cholinergic projections: Organization and vulnerability to degeneration","author":"Schmitz","year":"2021"},{"key":"10.1016\/j.nbas.2022.100039_b0015","doi-asserted-by":"crossref","unstructured":"Candy JM, Perry EK, Perry RH, et al. The current status of the cortical cholinergic system in Alzheimer\u2019s disease and Parkinson\u2019s disease. Prog Brain Res 1986; 70: 105-132. 1986\/01\/01. 10.1016\/s0079-6123(08)64300-9.","DOI":"10.1016\/S0079-6123(08)64300-9"},{"key":"10.1016\/j.nbas.2022.100039_b0020","doi-asserted-by":"crossref","unstructured":"Mesulam MM, Geula C. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comparative Neurol 1988; 275: 216-240. 1988\/09\/08. 10.1002\/cne.902750205.","DOI":"10.1002\/cne.902750205"},{"key":"10.1016\/j.nbas.2022.100039_b0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cne.903250107","article-title":"Cholinergic innervation of the human thalamus: dual origin and differential nuclear distribution","volume":"325","author":"Heckers","year":"1992","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.nbas.2022.100039_b0030","doi-asserted-by":"crossref","unstructured":"Zhang C, Zhou P, Yuan T. The cholinergic system in the cerebellum: from structure to function. Rev Neurosci 2016; 27: 769-772016\/08\/210.1515\/revneuro-2016-0008.","DOI":"10.1515\/revneuro-2016-0008"},{"key":"10.1016\/j.nbas.2022.100039_b0035","doi-asserted-by":"crossref","unstructured":"Dautan D, Hacioglu Bay H, Bolam JP, et al. Extrinsic sources of cholinergic innervation of the striatal complex: a whole-brain mapping analysis. Front Neuroanat 2016; 10: 1. 2016\/02\/03. 10.3389\/fnana.2016.00001.","DOI":"10.3389\/fnana.2016.00001"},{"key":"10.1016\/j.nbas.2022.100039_b0040","doi-asserted-by":"crossref","unstructured":"Janickova H, Rosborough K, Al-Onaizi M, et al. Deletion of the vesicular acetylcholine transporter from pedunculopontine\/laterodorsal tegmental neurons modifies gait. J Neurochem 2017; 140: 787-792016\/11\/210.1111\/jnc.13910.","DOI":"10.1111\/jnc.13910"},{"key":"10.1016\/j.nbas.2022.100039_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/cne.24541","article-title":"Regional vesicular acetylcholine transporter distribution in human brain: A [(18) F]fluoroethoxybenzovesamicol positron emission tomography study","author":"Albin","year":"2018","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.nbas.2022.100039_b0050","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2967\/jnumed.113.124792","article-title":"In vivo imaging of human cholinergic nerve terminals with (-)-5-18F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses","volume":"55","author":"Petrou","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nbas.2022.100039_b0055","doi-asserted-by":"crossref","unstructured":"Boertien JM, van der Zee S, Chrysou A, et al. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson\u2019s disease patients for the identification and validation of biomarkers for Parkinson\u2019s disease subtypes, progression and pathophysiology. BMC Neurol 2020; 20: 245. 2020\/06\/15. 10.1186\/s12883-020-01811-3.","DOI":"10.1186\/s12883-020-01811-3"},{"key":"10.1016\/j.nbas.2022.100039_b0060","doi-asserted-by":"crossref","unstructured":"Bohnen NI, Muller ML, Kotagal V, et al. Heterogeneity of cholinergic denervation in Parkinson\u2019s disease without dementia. J Cereb Blood Flow Metab 2012; 32: 1609-17. 2012\/05\/10. 10.1038\/jcbfm.2012.60.","DOI":"10.1038\/jcbfm.2012.60"},{"key":"10.1016\/j.nbas.2022.100039_b0065","doi-asserted-by":"crossref","unstructured":"Bohnen NI, Kanel P, Koeppe RA, et al. Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson\u2019s disease. Brain Commun 2021; 3: fcab109. https:\/\/doi.org\/10.1093\/braincomms\/fcab109.","DOI":"10.1093\/braincomms\/fcab109"},{"key":"10.1016\/j.nbas.2022.100039_b0070","doi-asserted-by":"crossref","unstructured":"Shao X, Hoareau R, Hockley BG, et al. Highlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN). J Label Compounds Radiopharmaceuticals 2011; 54: 292-307. 2011\/07\/20. 10.1002\/jlcr.1865.","DOI":"10.1002\/jlcr.1865"},{"key":"10.1016\/j.nbas.2022.100039_b0075","doi-asserted-by":"crossref","unstructured":"Thiele F, Young S, Buchert R, et al. Voxel-based classification of FDG PET in dementia using inter-scanner normalization. NeuroImage 2013; 77: 62-9. 2013\/04\/02. 10.1016\/j.neuroimage.2013.03.031.","DOI":"10.1016\/j.neuroimage.2013.03.031"},{"key":"10.1016\/j.nbas.2022.100039_b0080","doi-asserted-by":"crossref","unstructured":"Kanel P, M\u00fcller M, van der Zee S, et al. Topography of cholinergic changes in dementia with Lewy bodies and key neural network hubs. J Neuropsychiatry Clin Neurosci 2020; 32: 370-5. 2020\/06\/06. 10.1176\/appi.neuropsych.19070165.","DOI":"10.1176\/appi.neuropsych.19070165"},{"key":"10.1016\/j.nbas.2022.100039_b0085","doi-asserted-by":"crossref","unstructured":"Nejad-Davarani S, Koeppe RA, Albin RL, et al. Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [(18)F]-FEOBV. Mol Psychiatry 2019; 24: 322-327. 2018\/08\/08. 10.1038\/s41380-018-0130-5.","DOI":"10.1038\/s41380-018-0130-5"},{"key":"10.1016\/j.nbas.2022.100039_b0090","doi-asserted-by":"crossref","unstructured":"Albin RL, Minderovic C, Koeppe RA. Normal striatal vesicular acetylcholine transporter expression in Tourette syndrome. eNeuro 2017; 4 2017\/08\/10. 10.1523\/ENEURO.0178-17.2017.","DOI":"10.1523\/ENEURO.0178-17.2017"},{"key":"10.1016\/j.nbas.2022.100039_b0095","doi-asserted-by":"crossref","unstructured":"Muller-Gartner HW, Links JM, Prince JL, et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab 1992; 12: 571-583. 1992\/07\/01. 10.1038\/jcbfm.1992.81.","DOI":"10.1038\/jcbfm.1992.81"},{"issue":"988\u2013992","key":"10.1016\/j.nbas.2022.100039_b0100","first-page":"20200730","article-title":"Julich-Brain: a 3D probabilistic atlas of the human brain\u2019s cytoarchitecture","volume":"369","author":"Amunts","year":"2020","journal-title":"Science"},{"issue":"139\u2013145","key":"10.1016\/j.nbas.2022.100039_b0105","first-page":"20100104","article-title":"Centenary of Brodmann\u2019s map\u2013conception and fate","volume":"11","author":"Zilles","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.nbas.2022.100039_b0110","series-title":"Brain Mapping: The Methods","first-page":"573","article-title":"21 - Quantitative Analysis of Cyto- and Receptor Architecture of the Human Brain","author":"Zilles","year":"2002"},{"key":"10.1016\/j.nbas.2022.100039_b0115","doi-asserted-by":"crossref","unstructured":"Kuhl DE, Koeppe RA, Minoshima S, et al. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer\u2019s disease. Neurology 1999; 52: 691-9. 1999\/03\/17. DOI: 10.1212\/wnl.52.4.691.","DOI":"10.1212\/WNL.52.4.691"},{"key":"10.1016\/j.nbas.2022.100039_b0120","doi-asserted-by":"crossref","unstructured":"Mitsis EM, Cosgrove KP, Staley JK, et al. Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT. Neurobiol Aging 2009; 30: 1490-7. 2008\/02\/05. 10.1016\/j.neurobiolaging.2007.12.008.","DOI":"10.1016\/j.neurobiolaging.2007.12.008"},{"issue":"555\u2013561","key":"10.1016\/j.nbas.2022.100039_b0125","first-page":"20120425","article-title":"PET imaging of cholinergic deficits in rats using [18F]fluoroethoxybenzovesamicol ([18F]FEOBV)","volume":"62","author":"Parent","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbas.2022.100039_b0130","doi-asserted-by":"crossref","unstructured":"Zaborszky L, Csordas A, Mosca K, et al. Neurons in the basal forebrain project to the cortex in a complex topographic organization that reflects corticocortical connectivity patterns: an experimental study based on retrograde tracing and 3D reconstruction. Cereb Cortex (New York, NY : 1991) 2015; 25: 118-137. 2013\/08\/22. 10.1093\/cercor\/bht210.","DOI":"10.1093\/cercor\/bht210"},{"key":"10.1016\/j.nbas.2022.100039_b0135","doi-asserted-by":"crossref","unstructured":"Gielow MR and Zaborszky L. The input-output relationship of the cholinergic basal forebrain. Cell Rep 2017; 18: 1817-30. 2017\/02\/16. 10.1016\/j.celrep.2017.01.060.","DOI":"10.1016\/j.celrep.2017.01.060"},{"key":"10.1016\/j.nbas.2022.100039_b0140","doi-asserted-by":"crossref","unstructured":"van der Zee S, M\u00fcller MLTM, Kanel P, et al. Cholinergic denervation patterns across cognitive domains in Parkinson\u2019s disease. Movement Disord 2021; 36: 642-50. 2020\/11\/03. DOI: 10.1002\/mds.28360.","DOI":"10.1002\/mds.28360"},{"key":"10.1016\/j.nbas.2022.100039_b0145","doi-asserted-by":"crossref","unstructured":"Power JD, Cohen AL, Nelson SM, et al. Functional network organization of the human brain. Neuron 2011; 72: 665-78. 2011\/11\/22. 10.1016\/j.neuron.2011.09.006.","DOI":"10.1016\/j.neuron.2011.09.006"},{"key":"10.1016\/j.nbas.2022.100039_b0150","doi-asserted-by":"crossref","unstructured":"Sadaghiani S and D'Esposito M. Functional characterization of the Cingulo-opercular network in the maintenance of tonic alertness. Cereb cortex (New York, NY : 1991) 2015; 25: 2763-73. 2014\/04\/29. 10.1093\/cercor\/bhu072.","DOI":"10.1093\/cercor\/bhu072"},{"key":"10.1016\/j.nbas.2022.100039_b0155","doi-asserted-by":"crossref","unstructured":"Harada CN, Natelson Love MC and Triebel KL. Normal cognitive aging. Clin Geriatr Med 2013; 29: 737-52. 2013\/10\/08. 10.1016\/j.cger.2013.07.002.","DOI":"10.1016\/j.cger.2013.07.002"},{"key":"10.1016\/j.nbas.2022.100039_b0160","doi-asserted-by":"crossref","unstructured":"Zhang HY, Chen WX, Jiao Y, et al. Selective vulnerability related to aging in large-scale resting brain networks. PLoS One 2014; 9: e108807. 2014\/10\/02. 10.1371\/journal.pone.0108807.","DOI":"10.1371\/journal.pone.0108807"},{"key":"10.1016\/j.nbas.2022.100039_b0165","doi-asserted-by":"crossref","unstructured":"Aghourian M, Legault-Denis C, Soucy JP, et al. Quantification of brain cholinergic denervation in Alzheimer\u2019s disease using PET imaging with [(18)F]-FEOBV. Mol Psychiatry 2017; 22: 1531-1538. 2017\/09\/13. 10.1038\/mp.2017.183.","DOI":"10.1038\/mp.2017.183"},{"key":"10.1016\/j.nbas.2022.100039_b0170","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11910-021-01140-z","article-title":"Molecular imaging of the cholinergic system in alzheimer and lewy body dementias: expanding views","volume":"21","author":"Kanel","year":"2021","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.nbas.2022.100039_b0175","doi-asserted-by":"crossref","unstructured":"Bohnen NI, Kanel P, Koeppe RA, et al. Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson\u2019s disease. Brain Commun 2021; 3. ARTN fcab1091093\/braincomms\/fcab10910.1093\/braincomms\/fcab109.","DOI":"10.1093\/braincomms\/fcab109"},{"key":"10.1016\/j.nbas.2022.100039_b0180","doi-asserted-by":"crossref","unstructured":"de la Fuente-Fernandez R, Schulzer M, Kuramoto L, et al. Age-specific progression of nigrostriatal dysfunction in Parkinson\u2019s disease. Ann Neurol 2011; 69: 803-10. 2011\/01\/20. 10.1002\/ana.22284.","DOI":"10.1002\/ana.22284"},{"key":"10.1016\/j.nbas.2022.100039_b0185","doi-asserted-by":"crossref","unstructured":"Rodriguez M, Rodriguez-Sabate C, Morales I, et al. Parkinson\u2019s disease as a result of aging. Aging Cell 2015; 14: 293-308. 2015\/02\/14. 10.1111\/acel.12312.","DOI":"10.1111\/acel.12312"}],"container-title":["Aging Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589958922000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589958922000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:09Z","timestamp":1762905609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589958922000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":37,"alternative-id":["S2589958922000111"],"URL":"https:\/\/doi.org\/10.1016\/j.nbas.2022.100039","relation":{},"ISSN":["2589-9589"],"issn-type":[{"value":"2589-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET study","name":"articletitle","label":"Article Title"},{"value":"Aging Brain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbas.2022.100039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100039"}}